BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bellis A, Mauro C, Barbato E, Trimarco B, Morisco C. The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19. Int J Mol Sci 2020;21:E8612. [PMID: 33203141 DOI: 10.3390/ijms21228612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Scotece M, Conde-aranda J. Inflammation in Health and Disease: New Insights and Therapeutic Avenues. IJMS 2022;23:8392. [DOI: 10.3390/ijms23158392] [Reference Citation Analysis]
2 Philippe A, Kleinau G, Gruner J, Wu S, Postpieszala D, Speck D, Heidecke H, Dowell S, Riemekasten G, Hildebrand P, Kamhieh-milz J, Catar R, Szczepek M, Dragun D, Scheerer P. Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation. IJMS 2022;23:3984. [DOI: 10.3390/ijms23073984] [Reference Citation Analysis]
3 Simko F, Hrenak J, Adamcova M, Paulis L. Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions. Int J Mol Sci 2021;22:3217. [PMID: 33809971 DOI: 10.3390/ijms22063217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339 [PMID: 34589168 DOI: 10.4330/wjc.v13.i8.325] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Alves M, Fernandes MA, Bahat G, Benetos A, Clemente H, Grodzicki T, Martínez-Sellés M, Mattace-Raso F, Rajkumar C, Ungar A, Werner N, Strandberg TE; EuGMS Special Interest Group inCardiovascular Medicine (Chairpersons A. Ungar and A. Benetos). Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications. Eur Geriatr Med 2021;12:725-39. [PMID: 34031865 DOI: 10.1007/s41999-021-00504-5] [Reference Citation Analysis]
6 Speck D, Kleinau G, Szczepek M, Kwiatkowski D, Catar R, Philippe A, Scheerer P. Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting. Front Endocrinol 2022;13:880002. [DOI: 10.3389/fendo.2022.880002] [Reference Citation Analysis]
7 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]
8 Babajani F, Kakavand A, Mohammadi H, Sharifi A, Zakeri S, Asadi S, Afshar ZM, Rahimi Z, Sayad B. COVID-19 and renin angiotensin aldosterone system: Pathogenesis and therapy. Health Sci Rep 2021;4:e440. [PMID: 34869917 DOI: 10.1002/hsr2.440] [Reference Citation Analysis]
9 Khodabakhsh P, Asgari Taei A, Mohseni M, Bahrami Zanjanbar D, Khalili H, Masoumi K, Haji Abbas Shirazi A, Dargahi L. Vasoactive Peptides: Their Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets. Arch Med Res 2021:S0188-4409(21)00122-3. [PMID: 34134920 DOI: 10.1016/j.arcmed.2021.05.007] [Reference Citation Analysis]
10 Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. WJC 2021;13:326-40. [DOI: 10.4330/wjc.v13.i8.326] [Reference Citation Analysis]
11 Tepasse P, Vollenberg R, Steinebrey N, König S. High Angiotensin-Converting Enzyme and Low Carboxypeptidase N Serum Activity Correlate with Disease Severity in COVID-19 Patients. JPM 2022;12:406. [DOI: 10.3390/jpm12030406] [Reference Citation Analysis]
12 Turner AJ, Nalivaeva NN. Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]